Quick answer
The chief investigator and principal investigator titles usually name the same lead role: the person responsible for running a research study. The sponsor, regulator, funder or jurisdiction decides which title applies, and the governing policy sets the duties. This page is general information, not legal advice.
- For FDA-regulated drug studies, the federal term is "investigator," defined in 21 CFR 312.3.
- A sponsor can be a company, government agency or academic institution, according to the FDA definition in 21 CFR 312.3.
- For federally conducted, supported or regulated human-subjects research, 45 CFR Part 46 applies to institutions and institutional review boards.
What does a principal investigator do?
A principal investigator's duties come from the institution, funder and sponsor agreement. Under 21 CFR 312.3, FDA's term investigator means an individual who actually conducts a clinical investigation, meaning the drug is given or dispensed to a subject under that person's immediate direction. When a team carries out the study, the investigator is "the responsible leader of the team."
45 CFR Part 46 binds institutions and institutional review boards, but its text does not name a principal investigator. Institutions and funders may add duties such as protocol oversight, staff supervision and budget reporting.
What does a chief investigator do?
Some multi-site and multi-centre trials use chief investigator for the lead role across the whole study. Its meaning comes from the study documents, so read the trial protocol and governance documents first.
Chief investigator vs principal investigator: how the terms compare
The difference lies mainly in which framework uses each title.
| Principal investigator | Chief investigator | |
|---|---|---|
| Typical use | Lead of a study at one site or several | Title used in some multi-site trial governance; meaning set by the study documents |
| Governing rule or framework | Institution and funder policy; FDA uses "investigator" (21 CFR 312.3) | Trial protocol, governance documents and the sponsor's framework |
| Scope | Single site or multi-site, per the study design | Set by the protocol and governance documents |
| Final accountability | Set by institution, funder and sponsor agreement; for FDA team studies, the responsible leader of the team | Set by the protocol and governance documents |
Some studies use both titles, for example a chief investigator for the whole trial and a principal investigator at each site. Confirm that structure in the protocol.
Who can serve as a principal or chief investigator?
Eligibility is set by the institution, sponsor or regulator, not by one national rule. The FDA definition describes who conducts an investigation and does not list appointment criteria. Institutional policies may ask for appointment status, relevant training and disclosure of conflicts of interest, so ask your research office for its current policy.
What other roles sit beside the lead investigator?
Co-investigators, co-PIs, project directors and study coordinators hold roles that the study agreements set, so check the sponsor agreement before assuming any authority. A co-investigator may cover a defined project component rather than overall leadership, unless the sponsor agreement says otherwise.
Some institutions use the term Co-PI for a shared scientific and administrative leader. The NIH does not recognize the term Co-PI on its grant applications and uses Multiple PIs, according to the NCATS RaDaR glossary.
Under 21 CFR 312.3, "subinvestigator" includes any other individual member of the investigator's team.
Do not confuse these roles with a private investigator, who works in a different field. Private investigator duties and qualifications covers that role.
What records and reporting duties apply to the lead investigator?
For FDA-regulated drug studies, 21 CFR 312.62 requires the investigator to keep adequate records of the drug's disposition, including dates, quantities and use by subjects. The investigator must also keep accurate case histories, including signed and dated consent forms and medical records, and document that informed consent was obtained before a person joined the study. Records must be kept for 2 years after the marketing application is approved for the investigated indication. If no application is filed or approved, they must be kept for 2 years after the investigation is discontinued and FDA is notified.
Progress reporting, safety reporting and conflict-of-interest disclosure depend on the sponsor agreement and the institution's policy.
How do the terms differ by sponsor, regulator and jurisdiction?
The same duties can carry different names across sponsors, regulators and countries. US federal drug rules use the term investigator, and the federal human-subjects policy applies to institutions and review boards. UK trial practice may use the term chief investigator, so confirm the title for any UK study.
Frequently asked questions
Is a chief investigator the same as a principal investigator?
They usually describe the same lead role in practice, but the title and duties follow the sponsor, regulator, funder or jurisdiction for each study. Check the protocol and the governing policy to confirm which applies.
Which title do FDA-regulated studies use?
FDA's regulation uses the term investigator. Under 21 CFR 312.3, an investigator is an individual who actually conducts a clinical investigation, and the definition does not use the term principal investigator.
Who can serve as principal investigator at a university?
The university, its policies and the funder set eligibility, so there is no single national answer. Policies may ask for appointment status, training and disclosure of conflicts of interest, so check your institution's investigator policy.
What is the difference between a principal investigator and a co-investigator?
The sponsor agreement sets a co-investigator's role, which may cover a defined part of the project rather than overall leadership. The principal investigator's duties come from the institution, funder and sponsor documents.
Does the principal investigator hold final responsibility for the study?
For an FDA team study, 21 CFR 312.3 describes the investigator as the responsible leader of the team. Whether the principal investigator holds final responsibility in other settings depends on the institution, funder and sponsor documents, and disputes over that question are for an expert or a court.
Can one person be both the sponsor and the investigator?
Yes, under FDA's definitions. A sponsor-investigator is an individual who both initiates and conducts an investigation, and that person must meet both the investigator and sponsor requirements. A company or institution that uses its own employees to conduct a study is a sponsor, and those employees are investigators.
Where do I find the policy that sets the investigator title at my institution?
Start with your institution's research office, which administers investigator policies. The protocol and sponsor agreement for each study show the title used for that study.
Finding an expert witness on research-conduct questions
Attorneys and litigation teams can search expert profiles or request an AI-assisted match for expert witnesses on research-conduct questions. Legal Experts AI is a marketplace where attorneys and litigation teams find and retain expert witnesses. To start, use Get Matched with an expert witness or browse expert profiles.




